Paclitaxel: all 2,138 studies that test it

Page 7 of 22. Open to participants first (342), then studies with results posted, then the rest; newest registration first within each.

• GSK1120212 Rollover StudyTerminatedNCT01376310Phase 2Results posted
• CHFR Methylation Status Esophageal Cancer StudyTerminatedNCT01372202Phase 2Results posted
• A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsTerminatedNCT01369433Not applicableResults posted
• Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine CancerTerminatedNCT01367301Not applicableResults posted
• A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced MalignanciesCompletedNCT01325441Phase 1/2Results posted
• RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine DifferentiationCompletedNCT01317615Phase 4Results posted
• Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast CancerCompletedNCT01307891Phase 2Results posted
• Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC PatientsCompletedNCT01306942Phase 1/2Results posted
• LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment FailuresCompletedNCT01271725Phase 2Results posted
• Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric AdenocarcinomasCompletedNCT01253525Phase 1Results posted
• A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian CancerCompletedNCT01239732Phase 3Results posted
• MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor MalignanciesCompletedNCT01235897Phase 1Results posted
• Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast CancerTerminatedNCT01220128Phase 2Results posted
• Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary OvarianCompletedNCT01219777Phase 1Results posted
• First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial CarcinomaTerminatedNCT01215136Phase 2Results posted
• Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive StrategyCompletedNCT01209520Not applicableResults posted
• A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast CancersCompletedNCT01209195Phase 1Results posted
• Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast CancerTerminatedNCT01207102Phase 2Results posted
• Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal MelanomaTerminatedNCT01200342Phase 2Results posted
• CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)CompletedNCT01199055Phase 1Results posted
• Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian CancerCompletedNCT01196429Phase 2Results posted
• Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast CancerTerminatedNCT01194869Phase 2Results posted
• A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by SurgeryCompletedNCT01183559Phase 1Results posted
• Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal AdenocarcinomaTerminatedNCT01182610Phase 2Results posted
• A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in MelanomaCompletedNCT01174238Phase 2Results posted
• Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerActive, not recruitingNCT01167712Phase 3Results posted
• Neoadjuvant Therapy for Ovarian CancerCompletedNCT01146795Phase 2Results posted
• Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial CancerCompletedNCT01108055Phase 2Results posted
• Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV MelanomaCompletedNCT01107665Phase 2Results posted
• Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone SurgeryCompletedNCT01106898Phase 2Results posted
• A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)CompletedNCT01100931Phase 1/2Results posted
• First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT01097746Phase 2Results posted
• Hedgehog Inhibitors for Metastatic Adenocarcinoma of the PancreasCompletedNCT01088815Phase 2Results posted
• Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerActive, not recruitingNCT01081262Phase 3Results posted
• Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable AngiosarcomaTerminatedNCT01055028Phase 2Results posted
• Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal TumorsStatus unknownNCT01042522Phase 2Results posted
• Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial CancerTerminatedNCT01041027Phase 2Results posted
• Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerCompletedNCT01036087Phase 2Results posted
• Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT01031446Phase 1/2Results posted
• Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic MelanomaCompletedNCT01014351Phase 2Results posted
• Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung CancerCompletedNCT01011075Phase 2Results posted
• Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast CancerTerminatedNCT01009983Phase 2Results posted
• Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic MelanomaTerminatedNCT01009515Phase 2Results posted
• Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial CancerCompletedNCT01005329Phase 2Results posted
• Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial CancerTerminatedNCT00995488Phase 2Results posted
• Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical HysterectomyCompletedNCT00980954Phase 3Results posted
• Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerActive, not recruitingNCT00977574Phase 2Results posted
• Paclitaxel and CBT-1(Registered Trademark) to Treat Solid TumorsCompletedNCT00972205Not applicableResults posted
• Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast CancerCompletedNCT00971945Phase 2Results posted
• Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck CancerCompletedNCT00971867Phase 2Results posted
• Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal CancerCompletedNCT00971841Phase 2Results posted
• Combination Chemotherapy With CS-1008 to Treat Ovarian CancerCompletedNCT00945191Phase 2Results posted
• Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 ExpressionCompletedNCT00944047Phase 2Results posted
• A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian CancerCompletedNCT00937560Phase 2Results posted
• Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown PrimaryCompletedNCT00936702Phase 2Results posted
• Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast CaTerminatedNCT00934895Phase 1/2Results posted
• Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00888615Phase 2Results posted
• Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast CancerCompletedNCT00887575Phase 1/2Results posted
• Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown PrimaryCompletedNCT00873119Phase 2Results posted
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant MelanomaCompletedNCT00864253Phase 3Results posted
• Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck CancerCompletedNCT00851877Phase 1/2Results posted
• Treatment With Pazopanib for Neoadjuvant Breast CancerCompletedNCT00849472Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast CancerCompletedNCT00846027Phase 2Results posted
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the PancreasCompletedNCT00844649Phase 3Results posted
• Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian OriginTerminatedNCT00840450Phase 2Results posted
• Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck CancerCompletedNCT00833261Phase 2Results posted
• E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)CompletedNCT00832819Phase 1Results posted
• Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLCCompletedNCT00828841Phase 2Results posted
• Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerCompletedNCT00821964Phase 2Results posted
• Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194CompletedNCT00820170Phase 1/2Results posted
• Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid TumoursCompletedNCT00809133Phase 1Results posted
• Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial CancerStatus unknownNCT00807768Phase 3Results posted
• QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung CancerTerminatedNCT00807612Phase 1/2Results posted
• Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response AssessmentCompletedNCT00807573Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain MetastasisCompletedNCT00800202Phase 2Results posted
• Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, DacarbazineCompletedNCT00796991Phase 1Results posted
• Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerCompletedNCT00785291Phase 3Results posted
• Study Evaluating Safety And Tolerability, Solid TumorCompletedNCT00768469Phase 1Results posted
• Phase II Neoadjuvant in Inflammatory Breast CancerTerminatedNCT00756470Phase 2Results posted
• A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast CancerCompletedNCT00748553Phase 1/2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By SurgeryCompletedNCT00738361Phase 2Results posted
• Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary SiteCompletedNCT00737243Phase 2Results posted
• Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck CancerCompletedNCT00736944Phase 2Results posted
• A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung CancerCompletedNCT00735696Phase 2Results posted
• Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerCompletedNCT00733408Phase 2Results posted
• Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC PatientsCompletedNCT00730925Phase 2Results posted
• Sutent + Taxol for Advanced Esophageal CancerCompletedNCT00730353Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00729612Phase 2Results posted
• Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast CancerCompletedNCT00723125Phase 2Results posted
• Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBCCompletedNCT00709761Phase 2Results posted
• Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian CancerCompletedNCT00702299Phase 1Results posted
• Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine TherapyCompletedNCT00691054Phase 2Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast CancerCompletedNCT00675259Phase 2Results posted
• Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By SurgeryTerminatedNCT00662311Phase 1/2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00662129Phase 2Results posted
• S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00661193Phase 2Results posted
• Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast CancerCompletedNCT00656669Not applicableResults posted
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00654836Phase 2Results posted
• Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinCompletedNCT00635050Phase 2Results posted

← Paclitaxel overview